Cellular Energy
NAD+ helps mitochondria produce energy in cells. Whether supplements improve fatigue depends on its cause. Research has not established this benefit for all patients.
Explore medically supervised NAD+ delivery options with individualized evaluation, realistic expectations, and careful attention to safety and tolerability.

Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme in every living cell. It helps turn nutrients into energy. It also supports enzymes involved in DNA repair, cell signals, and metabolism.
Scientists actively study NAD+ in aging and metabolism. Oral precursors can raise certain NAD-related markers in people. However, research has not established that commercial NAD+ therapy reverses aging, prevents cancer or heart disease, treats depression, or extends human life.
Evidence matters: A biological mechanism is not the same as a proven clinical benefit. Before treatment, review goals, other options, uncertainty, product quality, and cost with your clinician.

Patients often ask about NAD+ for energy, clear thinking, recovery, and healthy aging. Responses vary, and evidence for specific wellness benefits remains limited.
NAD+ helps mitochondria produce energy in cells. Whether supplements improve fatigue depends on its cause. Research has not established this benefit for all patients.
Researchers study NAD+ pathways in brain aging and nerve health. However, NAD+ therapy is not an established treatment for memory loss, depression, or diseases that damage nerve cells.
Research continues in glucose regulation, inflammation, and lipid metabolism. Human trials of NMN have not consistently shown improvements in glucose or lipid measures.
Some precursor studies report changes in selected performance measures, while overall evidence for strength, muscle mass, and recovery remains mixed.
NAD+ levels and metabolism change with age. It remains unknown whether raising NAD+ through commercial therapy meaningfully changes human healthspan or lifespan.
Your starting health, medicines, treatment route, tolerance, and goals should guide decisions. A higher NAD+ level does not always mean a better outcome.
The routes are not interchangeable. They differ in how the body absorbs NAD+, evidence, ease of use, cost, and side effects. The best option depends on your health and clinical needs.
A clinician gives NAD+ into a vein and monitors the infusion. Although IV delivery is widely marketed, evidence of its benefits in people remains limited. The infusion rate strongly affects tolerance; faster is not better.
After medical review, your clinician may offer smaller-volume injections. Possible concerns include pain, redness, swelling, bruising, infection, systemic symptoms, and product-quality or sterility risks.
Oral NAD+ products are easy to take, but formulas and how the body processes them vary. There is little evidence that intact NAD+ taken by mouth has the same exposure or effects as an IV.
These compounds enter NAD+ synthesis pathways through different routes. In some studies, NR and NMN increase NAD-related markers. However, researchers are still studying the best dose, long-term safety, and meaningful health benefits.
The body makes NAD+ from vitamin B3 compounds and tryptophan. Food sources include poultry, fish, meat, dairy, legumes, peanuts, seeds, mushrooms, and whole grains. A varied diet supplies niacin and other nutrients needed for normal energy metabolism.
High-dose niacin or nicotinamide can cause side effects and may affect liver enzymes, glucose, uric acid, or medication tolerance. NR and NMN products vary in quality, and long-term outcome data are still developing. Your clinician should review supplements alongside kidney or liver disease, pregnancy, cancer treatment, diabetes, gout, and current medicines.

NAD+ should not be infused rapidly or pushed through significant discomfort. A slower, individualized rate may improve tolerability.
The infusion should be paused or slowed and the patient reassessed. Chest pain, breathing difficulty, fainting, severe shaking, low blood pressure, persistent vomiting, or signs of an allergic or contamination-related reaction require prompt medical evaluation.
Sterility and sourcing: FDA has reported severe chills, shaking, vomiting, and fatigue after compounded injectable NAD+ products and has warned that food-grade ingredients are not suitable for sterile compounding without appropriate processing. Injectable products should come from a qualified source using ingredients appropriate for sterile drug preparation.

First, a consultation should clarify what you want to improve. Your clinician can then assess whether established tests or treatments should come first. Fatigue, brain fog, low mood, and poor exercise tolerance have many possible causes. These include sleep disorders, anemia, thyroid disease, medicine effects, nutrient deficiencies, and heart or metabolic conditions.
Meet with our medical team to compare routes and review safety. Together, you can decide whether NAD+ therapy or a precursor option fits your goals.
Book An Appointment